Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)

Running trials

• Not yet recruiting

  A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

  NCT06941480· Phase 1· Source

• Recruiting

  A Study of Ropeg-Interferon in People With Polycythemia Vera

  NCT07886801· Phase 2· Source

• Recruiting

  A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer

  NCT07768436· Phase 2· Source

• Recruiting

  Radiation Therapy Approaches for People With Prostate Cancer

  NCT07751159· Phase 2· Source

• Recruiting

  A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

  NCT05751434· Phase 2· Source

• Recruiting

  A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer

  NCT07671339· Phase 1· Source

• Recruiting

  A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

  NCT07249528· Source

• Recruiting

  Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer

  NCT07548164· Phase 3· Source

• Recruiting

  A Study of Ivonescimab in People With Leiomyosarcoma

  NCT07516925· Phase 2· Source

• Recruiting

  HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

  NCT07459673· Phase 2· Source

• Recruiting

  A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

  NCT07392242· Phase 2· Source

• Recruiting

  A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

  NCT07390617· Source

• Active, not recruiting

  A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer

  NCT07335796· Phase 2· Source

• Recruiting

  A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

  NCT07323732· Phase 2· Source

• Recruiting

  A Study of Multiparametric Ultrasound Imaging Methods

  NCT07270237· Source

• Recruiting

  A Dietary Study for People With Multiple Myeloma

  NCT07226609· Source

• Recruiting

  A Study of 177Lu-PSMA-617 in People With Gliomas

  NCT07223034· Phase 1· Source

• Recruiting

  A Study of Surgery and Radiotherapy in People With Breast Cancer

  NCT07053085· Phase 2· Source

• Recruiting

  A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma

  NCT07105059· Phase 1· Source

• Recruiting

  A Study of Tarlatamab for People With Prostate Cancer

  NCT07111507· Phase 2· Source

• Recruiting

  A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

  NCT07063212· Phase 2· Source

• Recruiting

  A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

  NCT07011004· Phase 1· Source

• Recruiting

  A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer

  NCT06984861· Phase 2· Source

• Recruiting

  A Study of Hospital-at-Home for People Receiving Tarlatamab

  NCT06957314· Source

• Recruiting

  Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

  NCT06934889· Phase 1· Source

• Recruiting

  A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

  NCT06807632· Phase 1· Source

• Recruiting

  A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

  NCT06773195· Phase 1/2· Source

• Recruiting

  A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

  NCT06736613· Phase 2· Source

• Recruiting

  A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant

  NCT06679829· Phase 2· Source

• Active, not recruiting

  A Study of a Pelvic Floor Muscle Exercise Program Before and After Radical Prostatectomy

  NCT06671782· Source

• Recruiting

  A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

  NCT06637462· Source

• Recruiting

  A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma

  NCT06623396· Phase 1· Source

• Recruiting

  A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

  NCT06594991· Phase 2· Source

• Recruiting

  A Study of Sotorasib in People With Non-Small Cell Lung Cancer

  NCT06582771· Phase 2· Source

• Recruiting

  A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

  NCT06563479· Phase 3· Source

• Recruiting

  A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

  NCT06457919· Phase 1/2· Source

• Recruiting

  A Registry for People With Lung Cancer

  NCT06424327· Source

• Recruiting

  A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer

  NCT06394804· Phase 2· Source

• Active, not recruiting

  A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

  NCT06251973· Phase 2· Source

• Recruiting

  A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

  NCT06246968· Phase 1· Source

• Active, not recruiting

  A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy

  NCT06240598· Phase 2· Source

• Active, not recruiting

  A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma

  NCT06192888· Phase 1· Source

• Active, not recruiting

  A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

  NCT06110793· Phase 1/2· Source

• Recruiting

  A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer

  NCT06130280· Phase 2· Source

• Recruiting

  Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma

  NCT06129903· Source

• Recruiting

  A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

  NCT06099769· Phase 2· Source

• Recruiting

  A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy

  NCT06066346· Phase 2· Source

• Recruiting

  A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

  NCT06055894· Source

• Recruiting

  A Study of CRD3874-SI in People With Solid Tumors

  NCT06021626· Phase 1· Source

• Enrolling by invitation

  Improving Surgeon Performance Measures for Robot-Assisted Surgery

  NCT06037837· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer9 recruiting
• Multiple myeloma6 recruiting
• Prostate cancer6 recruiting
• Head and neck cancer5 recruiting
• Metastatic breast cancer5 recruiting
• Sarcoma5 recruiting
• Childhood cancers3 recruiting
• Pancreatic cancer3 recruiting
• Acute myeloid leukemia2 recruiting
• Bladder cancer2 recruiting
• Colorectal cancer2 recruiting
• Glioblastoma2 recruiting
• Kidney cancer2 recruiting
• Melanoma2 recruiting
• Myeloproliferative neoplasms2 recruiting
• Triple-negative breast cancer2 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Follicular lymphoma1 recruiting
• Mesothelioma1 recruiting
• Neuroendocrine tumours1 recruiting
• Ovarian cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

  NCT07414992· Phase 2· Source

• Withdrawn

  A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

  NCT07428044· Phase 2· Source

• Terminated

  A Study of XmAb23104 in People With Sarcoma

  NCT05879185· Phase 2· Source

• Completed

  A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

  NCT05429320· Phase 2· Source

• Completed

  A Study Comparing Geriatric Co-Management With Geriatric Guided Supportive Care in Older Patients Receiving Chemoradiation Therapy for Their Head and Neck Cancer

  NCT05239000· Source